An interventional study of Acceptance and Commitment Therapy in Obsessive-Compulsive Disorder (OCD), sponsored by University of Alabama at Birmingham. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-28.
Sponsored by University of Alabama at Birmingham · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 299 studies in Obsessive-Compulsive Disorder with a site in United States — 59 open to participants now, 77 under way, 2 of them phase 3. Obsessive-Compulsive Disorder · United States.
Among the 299 studies in Obsessive-Compulsive Disorder with a site in United States, this one is the 203rd largest by planned enrollment of the 246 interventional ones that give a count, is one of 17 that started in 2025, is one of 144 with no phase, reaches primary completion later than 24 of the 76 other live ones, and was the 276th registered.
636 studies on the registry are indexed under Obsessive-Compulsive Disorder; 166 are open to participants now.
Browse Obsessive-Compulsive Disorder studies →59 of the 299 studies in Obsessive-Compulsive Disorder with a site in United States are open now. Recruiting first, the newest first:
Nader Pouratian · Sites in United States
Ages 22–75
Attune Neurosciences Inc · Sites in United States
Ages 22–80
National Institute of Mental Health (NIMH) · Sites in United States
Ages 10–17 · Healthy volunteers
University of Pennsylvania · Sites in United States
Ages 22–80
Francisco A Moreno · Sites in United States
Ages 18+
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 119 Obsessive-Compulsive Disorder studies recruiting now, 30 (25%) set no upper age limit and 81 (68%) stop at 75 or younger; 28 take children under 18; 18 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
299 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 24 · Phase 2 63 · Phase 3 19 · Phase 4 15
First in 1988; this study’s year is marked. 17 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 10 is below the median of 45 across 521 interventional studies indexed under Obsessive-Compulsive Disorder.
Median enrollment 40 across the 246 interventional studies, 111 across the 50 observational. Of the 201 that completed or were terminated, 74 (37%) have results posted.
This tab as a report to print or save as PDF → With an account.
22 of 299 have an industry lead sponsor. The 10 most frequent:
University of Alabama at Birmingham is the lead sponsor of 1,421 studies on the registry; 277 are open to participants now.
Of its 164 completed or terminated interventional studies of FDA-regulated products, 130 (79%) have results posted.
University of Alabama at Birmingham has 1 study filed under Obsessive-Compulsive Disorder — fewer than ten, so there is no comparison to draw.
29 of the studies in Obsessive-Compulsive Disorder with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05467683Jasper A. SmitsCO2 Reactivity as a Biomarker of Non-Response to Exposure-Based Therapy | 2026-12-01 |
| NCT05783817Carolyn RodriguezMDMA-Assisted CBT for OCD (MDMA-CBT4OCD Study) | 2026-12-01 |
| NCT05546658Johns Hopkins UniversityEffects of Psilocybin in Obsessive Compulsive Disorder | 2026-12-30 |
| NCT03918577Stanford UniversityCaloric Vestibular Stimulation for Modulation of Insight in Obsessive-Compulsive Spectrum Disorders | 2026-12-30 |
| NCT05651295Matthew Southward, PhDA Precision Medicine Approach to Target Engagement for Emotion Regulation | 2026-12-31 |
Add all 29 to your calendar (.ics) → With an account.
Among the 299 studies in Obsessive-Compulsive Disorder with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purpose of the study is to examine the effects and feasibility of a specific form of psychotherapy, acceptance and commitment therapy (ACT), on religiously oriented obsessive and compulsive disorder (OCD).
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants will receive twelve consecutive weeks of acceptance and commitment therapy
Behavioral: Acceptance and Commitment Therapy
participants will then receive ACT-based individual therapy weekly for twelve weeks.
Scrupulosity Obsessions and Compulsions Scale
The Scrupulosity Obsessions and Compulsions Scale (SOCS) is a 10-item scale that asks participants how often they experience religious OCD obsessions and compulsions. The questions are asked on a scale ranging from 0 (Very Rarely) to 5 (Very Often).
Time frame: At baseline, 4 weeks, 8 weeks, and post-intervention (12 weeks)
Experiential Avoidance Rating Scale
The Experiential Avoidance Rating Scale (EARS) is a 6-item scale that asks participants how true statements about avoiding experiences are for them. The questions are asked on a scale ranging from 1 (Never True) to 5 (Very Often True).
Time frame: At baseline, 4 weeks, 8 weeks, and post-intervention (12 weeks)
Centrality of Religiosity Scale - Interreligious 20
The Centrality of Religiosity Scale - Interreligious 20 (CRSi-20) is a 20-item scale assessing religiosity across 5 dimensions (Intellect, Ideology, Public practice, Private practice, Experience). The questions are asked on scales ranging from Never to Several times a day, Never to Very often, and Not at all to Very much so.
Time frame: Pre and post intervention which in general lasts 12 weeks
Yale-Brown Obsessive and Compulsive Scale - Self Report
The Yale-Brown Obsessive and Compulsive Scale (Y-BOCS) is a 12-item scale that asks participants whether they experience various OCD obsessions and compulsions. Participants are then asked how much time is spent on these obsessions and compulsions, whether they give in to the urge to perform compulsions, how strong the drive is to give in to compulsions, how they would feel if they were prevented from engaging in compulsions, and how much the compulsions and avoidance of compulsions interfere with their functioning.
Time frame: Pre and post intervention which in general lasts 12 weeks
Patient Health Questionnaire - 9
The Patient Health Questionnaire (PHQ-9) is a 9-item scale that asks participants how often they have been bothered by aspects of depressive symptoms. The questions are asked on a scale ranging from 0 (Not at all) to 5 (Nearly every day).
Time frame: Pre and post intervention which in general lasts 12 weeks
Generalized Anxiety Disorder - 7
The Generalized Anxiety Disorder Scale (GAD-7) is a 7-item scale that asks participants how often they have been bothered by statements capturing aspects of anxiety. The questions are asked on a scale ranging from 0 (Not at all) to 3 (Nearly every day).
Time frame: Pre and post intervention which in general lasts 12 weeks
The Intrinsic Spirituality Scale
The Intrinsic Spirituality Scale is a 6-item scale that asks participants about aspects of their spirituality.
Time frame: Pre and post intervention which in general lasts 12 weeks
Psy-Flex
The Psyflex questionnaire is a 6-item scale that measures aspects of psychological flexibility. The questions are asked on a scale ranging from very seldom to often.
Time frame: Pre and post intervention which in general lasts 12 weeks
Almost Perfect Scale - Revised
The Almost Perfect Scale - Revised is a 23-item scale that asks participants their agreement on items capturing perfectionism. The questions are asked on a scale ranging from 1 (Strongly disagree) to 7 (Strongly agree).
Time frame: Pre and post intervention which in general lasts 12 weeks
The Alcohol Use Disorders Identification Test
The Alcohol Use Disorders Identification Test (AUDIT) is a 10-item scale that asks participants about their alcohol consumption.
Time frame: Pre and post intervention which in general lasts 12 weeks
National Institute on Drug Abuse Screener
National Institute on Drug Abuse Screener (NIDA) is a 1-item scale that asks participants how often they use a variety of substances. The questions are asked on a scale ranging from Never to Daily or Almost Daily.
Time frame: Pre and post intervention which in general lasts 12 weeks
Plan to share: Yes
No publications or documents are linked to this record.
Started Jul 2025 (actual). Primary completion is estimated for Mar 2027, 19 months after the start.
Of 234 non-industry interventional studies with no phase under Obsessive-Compulsive Disorder, half reached primary completion within 43 months of starting (the median), counting those still running; a quarter within 22 and three quarters within 65. This study's planned 19 months is below that.
Counting every sponsor, half of 237 studies reached it within 43 months; a quarter within 22 and three quarters within 65.
Since we started tracking on Sep 25, 2026, the dates moved once, on Sep 28, 2026: primary completion Sep 2026 → Mar 2027 and completion Sep 2026 → Mar 2027.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Obsessive-Compulsive Disorder →
University of Alabama at Birmingham →